GetTopicDetailResponse(id=21c890e37f5, topicName=視網(wǎng)膜中央動脈阻塞, introduction=視網(wǎng)膜中央動脈阻塞, content=null, image=null, comments=3, allHits=1487, url=https://h5.medsci.cn/topic?id=90737, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=69323, tagList=[TagDto(tagId=69323, tagName=視網(wǎng)膜中央動脈阻塞)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2223187, encodeId=069b222318e60, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#視神經(jīng)病變#</a> <a href='/topic/show?id=21c890e37f5' target=_blank style='color:#2F92EE;'>#視網(wǎng)膜中央動脈阻塞#</a> <a href='/topic/show?id=91c611854194' target=_blank style='color:#2F92EE;'>#PRP注射#</a>, objectTitle=PRP眉間注射后，單側視力喪失, objectType=article, longId=841024, objectId=ee03841024a4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240719/1721369354422_8538692.jpg, objectUrl=/article/show_article.do?id=ee03841024a4, replyNumber=0, likeNumber=100, createdTime=2024-08-30, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ee03841024a4, moduleTitle=PRP眉間注射后，單側視力喪失, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ee03841024a4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1573195, encodeId=f8a215e31955d, content=<a href='/topic/show?id=21c890e37f5' target=_blank style='color:#2F92EE;'>#視網(wǎng)膜中央動脈阻塞#</a>, objectTitle=Stroke：視網(wǎng)膜中央動脈阻塞后房顫的檢出率, objectType=article, longId=212536, objectId=571521253654, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=571521253654, replyNumber=0, likeNumber=90, createdTime=2021-06-11, rootId=0, userName=zxxiang, userId=a29b15833374, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=571521253654, moduleTitle=Stroke：視網(wǎng)膜中央動脈阻塞后房顫的檢出率, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=571521253654)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573194, encodeId=216115e31945b, content=<a href='/topic/show?id=21c890e37f5' target=_blank style='color:#2F92EE;'>#視網(wǎng)膜中央動脈阻塞#</a>, objectTitle=Stroke：視網(wǎng)膜中央動脈阻塞患者的靜脈纖溶治療, objectType=article, longId=196122, objectId=01691961221e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01691961221e, replyNumber=0, likeNumber=100, createdTime=2020-06-21, rootId=0, userName=zxxiang, userId=a29b15833374, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01691961221e, moduleTitle=Stroke：視網(wǎng)膜中央動脈阻塞患者的靜脈纖溶治療, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=01691961221e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573193, encodeId=bace15e3193a0, content=<a href='/topic/show?id=21c890e37f5' target=_blank style='color:#2F92EE;'>#視網(wǎng)膜中央動脈阻塞#</a>, objectTitle=Facial Plast Surg：動脈內溶栓治療不是填充物相關的視網(wǎng)膜中央動脈阻塞的治療措施！, objectType=article, longId=128464, objectId=806112846467, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=806112846467, replyNumber=0, likeNumber=116, createdTime=2018-02-02, rootId=0, userName=zxxiang, userId=a29b15833374, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=806112846467, moduleTitle=Facial Plast Surg：動脈內溶栓治療不是填充物相關的視網(wǎng)膜中央動脈阻塞的治療措施！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=806112846467)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
